東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Fatty Acid Required for Glucose-Indu...

Allen, Ronald.

Linked to FindBook

Google Book

Amazon

博客來

Fatty Acid Required for Glucose-Induced Change in Beta Cell Plasma Membrane Potential Leading to Insulin Secretion.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Fatty Acid Required for Glucose-Induced Change in Beta Cell Plasma Membrane Potential Leading to Insulin Secretion./
Author:	Allen, Ronald.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
Description:	51 p.
Notes:	Source: Masters Abstracts International, Volume: 80-09.
Contained By:	Masters Abstracts International80-09.
Subject:	Endocrinology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13421381
ISBN:	9780438961760

Fatty Acid Required for Glucose-Induced Change in Beta Cell Plasma Membrane Potential Leading to Insulin Secretion.
Allen, Ronald.

Fatty Acid Required for Glucose-Induced Change in Beta Cell Plasma Membrane Potential Leading to Insulin Secretion. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 51 p.

Source: Masters Abstracts International, Volume: 80-09.

Thesis (M.S.)--Boston University, 2019.

This item must not be sold to any third party vendors.

The pancreatic β-cell secretes insulin through a combination of triggering and amplification pathways in response to glucose. Glucose metabolism is known to increase intracellular calcium and trigger insulin secretion from the β-cell while fatty acid (FA), an essential component of glucose stimulated insulin secretion (GSIS), is known to amplify secretion through varied mechanisms. Orlistat, a lipase inhibitor, blocks GSIS although the mechanism has not been clearly elucidated. We show that orlistat can also inhibit basal insulin secretion. FA can prevent/reverse orlistat-induced inhibition of secretion but fails to amplify GSIS after orlistat treatment. Here we test the hypothesis that FA is required to maintain normal plasma membrane potential and calcium influx in the β-cell. Clonal pancreatic β-cells (INS-1 832/13) were cultured in RPMI media containing 11 mM glucose and 10% FBS. Insulin secretion was measured over 2 hours with and without FA and orlistat (200 μM) using homogeneous time resolved fluorescence insulin assay (HTRF, Cisbio) and reported as ng/million cells. Intracellular calcium was measured in single cells using fura-2 AM. Single cell membrane potential was measured with virally expressed ARC Lite protein (Montana molecular). High glucose (8 mM) stimulated insulin secretion at least 3-fold over basal glucose (2 mM) and addition of FA enhanced GSIS. Orlistat almost completely abolished GSIS. This inhibition was mostly prevented in the presence of FA. Orlistat blocked calcium influx required for triggering insulin release while addition of FA recovered normal calcium homeostasis. The monoacylglycerol lipase inhibitor JZL 184 reduced both calcium influx and the increase in plasma membrane potential induced by KCl. FA recovered plasma membrane potential inhibited by JZL 184. Our results suggest that reducing β-cell intracellular FA availability by lipase inhibition blocks GSIS by preventing the glucose-induced rise in plasma membrane potential required to induce β-cell calcium influx through voltage dependent calcium channels (VDCC). FA is thus required to maintain normal nutrient metabolic coupling to insulin secretion. Whether the effect of FA to modulate plasma membrane potential plays a role in β-cell insulin hypersecretion resulting from excess nutrients requires further investigation.

ISBN: 9780438961760Subjects--Topical Terms:

610914
Endocrinology.

Fatty Acid Required for Glucose-Induced Change in Beta Cell Plasma Membrane Potential Leading to Insulin Secretion.
LDR:03483nmm a2200349 4500 001 2208787
005 20191025102414.5
008 201008s2019 ||||||||||||||||| ||eng d
020 $a 9780438961760
035 $a (MiAaPQ)AAI13421381
035 $a (MiAaPQ)bu:14303
035 $a AAI13421381
040 $a MiAaPQ $c MiAaPQ
100 1 $a Allen, Ronald. $3 3435837
245 1 0 $a Fatty Acid Required for Glucose-Induced Change in Beta Cell Plasma Membrane Potential Leading to Insulin Secretion.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 51 p.
500 $a Source: Masters Abstracts International, Volume: 80-09.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Corkey, Barbara E.;Deeney, Jude T.
502 $a Thesis (M.S.)--Boston University, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a The pancreatic β-cell secretes insulin through a combination of triggering and amplification pathways in response to glucose. Glucose metabolism is known to increase intracellular calcium and trigger insulin secretion from the β-cell while fatty acid (FA), an essential component of glucose stimulated insulin secretion (GSIS), is known to amplify secretion through varied mechanisms. Orlistat, a lipase inhibitor, blocks GSIS although the mechanism has not been clearly elucidated. We show that orlistat can also inhibit basal insulin secretion. FA can prevent/reverse orlistat-induced inhibition of secretion but fails to amplify GSIS after orlistat treatment. Here we test the hypothesis that FA is required to maintain normal plasma membrane potential and calcium influx in the β-cell. Clonal pancreatic β-cells (INS-1 832/13) were cultured in RPMI media containing 11 mM glucose and 10% FBS. Insulin secretion was measured over 2 hours with and without FA and orlistat (200 μM) using homogeneous time resolved fluorescence insulin assay (HTRF, Cisbio) and reported as ng/million cells. Intracellular calcium was measured in single cells using fura-2 AM. Single cell membrane potential was measured with virally expressed ARC Lite protein (Montana molecular). High glucose (8 mM) stimulated insulin secretion at least 3-fold over basal glucose (2 mM) and addition of FA enhanced GSIS. Orlistat almost completely abolished GSIS. This inhibition was mostly prevented in the presence of FA. Orlistat blocked calcium influx required for triggering insulin release while addition of FA recovered normal calcium homeostasis. The monoacylglycerol lipase inhibitor JZL 184 reduced both calcium influx and the increase in plasma membrane potential induced by KCl. FA recovered plasma membrane potential inhibited by JZL 184. Our results suggest that reducing β-cell intracellular FA availability by lipase inhibition blocks GSIS by preventing the glucose-induced rise in plasma membrane potential required to induce β-cell calcium influx through voltage dependent calcium channels (VDCC). FA is thus required to maintain normal nutrient metabolic coupling to insulin secretion. Whether the effect of FA to modulate plasma membrane potential plays a role in β-cell insulin hypersecretion resulting from excess nutrients requires further investigation.
590 $a School code: 0017.
650 4 $a Endocrinology. $3 610914
650 4 $a Medicine. $3 641104
650 4 $a Nutrition. $3 517777
650 4 $a Physiology. $3 518431
690 $a 0409
690 $a 0564
690 $a 0570
690 $a 0719
710 2 $a Boston University. $b Nutrition and Metabolism. $3 2102642
773 0 $t Masters Abstracts International $g 80-09.
790 $a 0017
791 $a M.S.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13421381